Interim Results From ERADICATE: An Open-Label Phase 2 Study of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Castration-Resistant Prostate Cancer Subjects With Symptomatic Bone Metastases
Clinical Advances in Hematology and Oncology H&o 14(4 Suppl. 5): 3-7
2016
ISSN/ISBN: 1543-0790 PMID: 27167841 Document Number: 686648
Document emailed within 1 workday
Related Documents
2016: Radium-223 (Ra-223) Re-Treatment (Re-tx): First Experience From an International, Multicenter, Prospective Study in Patients (Pts) With Castration-Resistant Prostate Cancer and Bone Metastases (mCRPC) Clinical Advances in Hematology and Oncology: H&o 14(4 Suppl. 5): 10-11Bourlon, M.T.; Glodé, L.M.; Crawford, E.D. 2014: Base of the skull metastases in metastatic castration-resistant prostate cancer Oncology 28(12): 1115-1116; 1124
Rosenbaum, J.F.; Fava, M.; Falk, W.E.; Pollack, M.H.; Cohen, L.S.; Cohen, B.M.; Zubenko, G.S. 1988: An open-label pilot study of oral S-adenosyl-L-methionine in major depression: interim results Psychopharmacology Bulletin 24(1): 189-194
Considine, B.; Petrylak, D.P. 2019: Integrating Novel Targets and Precision Medicine into Prostate Cancer Care-Part 1: the Non-Androgen-Targetable Pathways in Castration-Resistant Prostate Cancer Oncology 33(3): 113-118
Volf, E.M.; Au, S.-C.; Dumont, N.; Scheinman, P.; Gottlieb, A.B. 2012: A phase 2, open-label, investigator-initiated study to evaluate the safety and efficacy of apremilast in subjects with recalcitrant allergic contact or atopic dermatitis Journal of Drugs in Dermatology: Jdd 11(3): 341-346
De Souza, A.; Strober, B.E.; Merola, J.F.; Oliver, S.; Franks, A.G. 2012: Apremilast for discoid lupus erythematosus: results of a phase 2, open-label, single-arm, pilot study Journal of Drugs in Dermatology: Jdd 11(10): 1224-1226
Draelos, Z.ë D.; Feldman, S.R.; Butners, V.; Alió Saenz, A.B. 2013: Long-term safety of ketoconazole foam, 2% in the treatment of seborrheic dermatitis: results of a phase IV, open-label study Journal of Drugs in Dermatology: Jdd 12(1): E1-E6
Fearon, K.C.; Falconer, J.S.; Ross, J.A.; Carter, D.C.; Hunter, J.O.; Reynolds, P.D.; Tuffnell, Q. 1996: An open-label phase I/Ii dose escalation study of the treatment of pancreatic cancer using lithium gammalinolenate Anticancer Research 16(2): 867-874
Yokota, S.; Imagawa, T.; Nishikomori, R.; Takada, H.; Abrams, K.; Lheritier, K.; Heike, T.; Hara, T. 2017: Long-term safety and efficacy of canakinumab in cryopyrin-associated periodic syndrome: results from an open-label, phase IIi pivotal study in Japanese patients Clinical and Experimental Rheumatology 35 Suppl 108(6): 19-26
Rosino, A.; Ballester, I.; Tudela, J.án.; González-Billalabeitia, E. 2018: Chemotherapy in metastatic castration resistant prostate cancer Archivos Espanoles de Urologia 71(8): 676-684
Vázquez-Alonso, F.; Puche-Sanz, I.; Cózar-Olmo, J.é M. 2018: Recommendations for follow up in castration resistant prostate cancer Archivos Espanoles de Urologia 71(8): 735-742
Naito, S.; Shiota, M. 2014: The concept and mechanisms of castration-resistant prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 72(12): 2090-2094
Ojeda, A.V.; Ledo, M.ía.J.é; Alvarez-Ossorio, J.é L.ís. 2018: Sequencing and combination of agents in castration resistant prostate cancer Archivos Espanoles de Urologia 71(8): 711-720
Gomella, L.G.; Petrylak, D.P.; Shayegan, B. 2014: Current management of advanced and castration resistant prostate cancer Canadian Journal of Urology 21(2 Supp 1): 1-6
Miyake, H.; Fujisawa, M. 2014: Antisense oligodeoxynucleotide therapy for castration-resistant prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 72(12): 2121-2125
Bishr, M.; Lattouf, J.B.; Gannon, P.O.; Saad, F. 2011: Updates on therapeutic targets and agents in castration-resistant prostate cancer Minerva Urologica e Nefrologica 63(2): 131-143
Maeno, A.; Habuchi, T. 2016: Current status of castration-resistant prostate cancer translational research Nihon Rinsho. Japanese Journal of Clinical Medicine 74(1): 40-44
Rajna, P.ét.; Szíjártó, E. 2006: Efficacy, safety and effect on the quality of life of gabapentin in adult epilepsy--results of a prospective open-label quasi naturalistic Hungarian multicenter study (phase human-IV) Ideggyogyaszati Szemle 59(9-10): 361-372
Wang, W.; Peng, R.-x.; Shi, G.-w.; Chen, S.-y.; Ding, Q.; He, J.-y. 2015: Treatment of castration-resistant prostate cancer: Evidence-based clinical practice Zhonghua Nan Ke Xue 21(12): 1121-1124
Hu, Y.-H.; Guo, J.-C.; Zhang, M. 2017: Bipolar androgen therapy: a novel therapeutic strategy for castration-resistant prostate cancer Zhonghua Nan Ke Xue 23(12): 1138-1140